COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Disentangled multimodal evolutionary representations for cross-virus predictive modeling of antigenic change
Zhang, Z., Lin, Y., Zhong, S., Zhou, P., Li, Y., Yu, F.
10.64898/2026.02.12.705501 — Posted: 2026-02-13
White-tailed deer milk exhibits SARS-CoV-2 neutralizing antibodies and synergistic mechanisms that contribute to rapid viral RNA degradation
tobar, l. p., smith, w., raso, h. a., brown, k. l., ceci, a., urbano, m. g., roby, c., Mahmutovic, D., Biesemier, A. p., capelluto, d. G. S., aiello, i., raso, d. s., Finkielstein, C. V.
10.64898/2026.02.11.705256 — Posted: 2026-02-12
Antibody-Dependent Heterotypic Syncytia Drive COVID-19 Inflammation and Disease Progression
Yang, Y., Zhou, C., Zhang, T., Hu, W., Magazine, N., Carossino, M., Jia, N., Li, T., Wang, Y., Wang, C., Huang, J., Huang, W., Wu, F.
10.64898/2026.02.11.705426 — Posted: 2026-02-12
A Novel Secretome Rewrites the Immune Response in Viral Acute Respiratory Distress Syndrome
Lapuente, D., Mendoza Calvo, N., Lehmann, C. P., Garcia, B., Quintana, J. A., De Gregorio, A., Carpio, K., Galan-Martinez, J., R. Garcia-Rendueles, A., Camacho-Toledano, C., Oroz-Gonjar, F., Desportes, P., Sanz, J., Fernandez, P., De Gregorio, J. C., Sarno, F., Lapuente, J. P.
10.64898/2026.02.06.704035 — Posted: 2026-02-09
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines
Kim, B., Roenicke, R., Roeder, P. M., Steinberg, I., Patamawenu, A., Harrison, M., Veer, F. v., Koory, E., Xie, J., Shofner, T., Matsuda, K., Wettstein, E., Ober, E., Cooney, C., Kim, T., Webber, J. D., Meeks, T., Burdette, T., Clark, S. G., Vostal, A. C., Hostal, A., Cohen, J. I., Gagne, M., Ziff, Z., Richard, K., Burnett, M. R., Maule, E., Callier, V., Liang, J., Kovacikova, G., Souter, S. C., Weiner, J. A., Douek, D., Ackerman, M. E., Wright, P. F., Johnson, R. F., Connors, M.
10.64898/2026.02.04.703921 — Posted: 2026-02-05
ACE-2-like Enzymatic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal Antibodies
Song, Y., Mehl, F., No, T., Livingston, L., Quintero Barbosa, J. S., Hayashi, J., Serrero, G., Bortz, P. S., Wilson, J., Crowe, J. E., Ho, D. D., Yin, M. T., Tan, J., Zeichner, S. L.
10.64898/2026.02.02.703244 — Posted: 2026-02-05
Functional and Structural Basis of Omicron BA.3.2.1 Spike
Wang, Y., Hu, Y., Chen, Z., Zou, J., Zhang, K., Ren, P., Shi, P.-Y., Liang, B., Xie, X.
10.64898/2026.02.02.702852 — Posted: 2026-02-03
Multiorgan Outcomes Following COVID-19 Vaccine vs Infection: 30M Analysis
Toraih, E. A., Bruce, D., Hussein, M. H., Aiash, H., Thomas, S. J.
10.64898/2026.01.30.25343064 — Posted: 2026-02-03
A Cross-Sectional Study of COVID-19 Vaccine Hesitancy and Behaviours among People Living with HIV in British Columbia
Ejiegbu, A. E., Shariati, B., Little, J., Brondani, M.
10.64898/2026.01.31.26345295 — Posted: 2026-02-03
SEVA: An externally driven framework for reproducing COVID-19 mortality waves without transmission feedback
Varming, K.
10.64898/2026.01.30.26345245 — Posted: 2026-02-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).